Pseudophakic Cystoid Macular Lesions After Uncomplicated Standard Phacoemulsification
Completed
- Conditions
- Pseudophakic Cystoid Macular Lesions After Uncomplicated Standard Phacoemulsification
- Interventions
- Registration Number
- NCT03106402
- Lead Sponsor
- Kyungpook National University Hospital
- Brief Summary
To assess the incidence, risk factors and clinical courses of cystic macular lesions (CMLs) after uncomplicated phacoemulsification and evaluate the efficacy of topical NSAIDs on the prevention of pseudophakic cystic macular lesions
- Detailed Description
344 Patients undergoing uncomplicated standard phacoemulsification at Kyungpook National University Hospital from 2013 to 2015 were reviewed. CMLs, which is any cystic fluid collections after cataract surgery, were confirmed by preoperative and postoperative optical coherence tomography(OCT) on preoperative, postoperative 1month and 3months examinations. CMLs were classified into two groups: cystic macular edema(CME) and microcystic macular edema(MME).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 316
Inclusion Criteria
- patients who had phacoemulsification and were treated postoperatively at the Kyungpook National University Hospital, Daegu, Korea, from Oct 2013 to June 2015.
Exclusion Criteria
- patients had complicated cataract surgery (eg, significant corneal edema, posterior capsule rupture, vitreous loss, dropped nuclear material, retained cortical material, or an IOL not placed in the capsular bag)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Treated with topical NSAID topical bromfenac sodium hydrate 197 eyes of - patients were treated with topical bromfenac sodium hydrate (Bronuck®, Taejoon Pharm. LTD.) 2times a day starting 1 day before surgery and continued for 2 weeks after surgery.
- Primary Outcome Measures
Name Time Method Incidence of CMLs 12 weeks
- Secondary Outcome Measures
Name Time Method